Logi-Vent GmbH - Home-Use-Device Working Group

Tweet this page
<
2020
2021
>
No longer registered as of 13 May 2022 - Registration as it was on 27 Feb 2021
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

9,999€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

0.5 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Logi-Vent GmbH - Home-Use-Device Working Group   (HUD)

    EU Transparency Register

    584498237462-58 First registered on 26 Feb 2020

    Goals / Remit

    1. With the publication in May 2017 of the new Medical Device Regulation 2017/745 (MDR), the Logi-Vent’s Home Use Devices Safety Working Group (HUD) actively works with independent SME industry manufacturers and suppliers of home use appliances, without an intended medical purpose, in order to ensure safety of products in the hands of consumers.
    2. Logi-Vent’s HUD undertakes research projects with University of Wales and University of Aalborg, including a Level of Evidence review study on HUDs in hair reduction, which was published in August 2019 in Lasers in Surgery & Medicine entitled: ‘Light-based home-use devices for hair removal: Why do they work and how effective they are?’. In 2019 Logi-Vent’s HUD initiated an innovative research project aimed at understanding the role of social media in HUDs’ consumer adoption and commenced cross-sectional analysis research into YouTube videos on light-based home-use devices for acne vulgaris. This research project is aimed at assessing (...)

    Main EU files targeted

    1. Implementation of the MDR 2017/745 entered into force on 25 May 2017.
    In particular the development of Common Specifications (CS) by the MDCG Working Group to the Annex XVI Subgroup of the MDR Coordination Group appointed by DG SANTE.
    2. The activities of the MDCG Subgroup on standards especially completion of the process for issuing a new mandate to CEN/CENELEC for harmonized standards and the development of CS to facilitate Presumption of Conformity for Group 5 products listed in Annex XVI, with no intended medical purpose.
    3. The consultation on significant changes under article 120 to devices covered by MDD certificates and the development of Sufficient Clinical Evidence for Group 5 products listed in Annex XVI, with no intended medical purpose.
    4. The consultation on Borderline & Classification by the BCWG in respect of Group 5 products listed in Annex XVI, with no intended medical purpose.

    Address

    Head Office
    Michael Gillner
    Industriestrasse 11
    BASSUM 27211
    GERMANY
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    50%1

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    9,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard